Event Group
Event Groups are part of the Adverse Events Module within the Results Section. They provide a way to organize and summarize adverse event data by grouping related events together.
Each Event Group typically represents a category or class of adverse events and includes statistical information such as the number of participants affected and at risk for different event types: deaths, serious events, and other events.
Event Group path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Group
Event Group
Ignite Creation Date:
2025-12-25 @ 2:31 AM
Ignite Modification Date:
2025-12-26 @ 1:07 AM
NCT ID:
NCT00617734
Group ID:
EG001
Title:
IMC-A12 (Cixutumumab) + Cetuximab
Description:
IMC-A12 (cixutumumab) 10 mg/kg dose administered as an IV infusion over a period of 1 hour followed by cetuximab 500 mg/m\^2 dose administered as an IV infusion over a period of 2 hours; this sequence was repeated once every 2 weeks (4-week cycle). Treatment was continued until there was evidence of PD, unacceptable toxicity, or withdrawal of consent.
Deaths Number Affected:
None
Deaths Number At Risk:
None
Serious Number Affected:
23
Serious Number At Risk:
44
Other Number Affected:
44
Other Number At Risk:
44
Study:
NCT00617734
Results Section:
NCT00617734
Adverse Events Module:
NCT00617734